Skip to main navigation
  • UNDERSTANDING THE BODY
    • The Endocrine System
    • The Menstrual Cycle
  • OUR SCIENCE
    • Relugolix
    • MVT-602
    • Pipeline
    • Clinical Trials
  • OUR FOCUS
    • The Problem
    • Uterine Fibroids
    • Endometriosis
    • Prostate Cancer
    • Infertility
  • OUR ADVOCACY
    • Female Forward
    • Our Partnerships
    • Get Involved
  • WHO WE ARE
    • Our Purpose
    • Our Leadership
  • JOIN THE TEAM
    • Our Culture
    • Where We Call Home
    • Benefits
    • Careers
  • Investors & Media
    • Company Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
    • Corporate Governance
      • Board of Directors
      • Documents & Charters
      • Committee Composition
      • Expanded Access
    • Email Alerts
  • Contact Us

Press Releases

Press Releases

January 6, 2020
Myovant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

Toolkit

Print Page
RSS Feeds
Email Alerts
Contact
Search
  • UNDERSTANDING THE BODY
    • The Endocrine System
    • The Menstrual Cycle
  • OUR SCIENCE
    • Relugolix
    • MVT-602
    • Pipeline
    • Clinical Trials
  • OUR FOCUS
    • The Problem
    • Uterine Fibroids
    • Endometriosis
    • Prostate Cancer
    • Infertility
  • OUR ADVOCACY
    • Female Forward
    • Our Partnerships
    • Get Involved
  • WHO WE ARE
    • Our Purpose
    • Our Leadership
  • JOIN THE TEAM
    • Our Culture
    • Where We Call Home
    • Benefits
    • Careers
  • Investors & Media
    • Company Overview
    • News & Events
    • Stock Information
    • Financials & Filings
    • Corporate Governance
    • Email Alerts
  • Contact Us
© 2020 Myovant Sciences Ltd. 2000 Sierra Point Parkway, 9th Floor, Brisbane, CA 94005 Terms of Use Privacy Policy Cookie Policy